Lv11
2 积分 2023-08-29 加入
Engineered T cells Flt around their targets
1小时前
待确认
Adoptive cellular therapy with T cells expressing the dendritic cell growth factor Flt3L drives epitope spreading and antitumor immunity
1小时前
已完结
In vivo imaging reveals a tumor-associated macrophage–mediated resistance pathway in anti–PD-1 therapy
7天前
已完结
Anti-CTLA-4 antibodies drive myeloid activation and reprogram the tumor microenvironment through FcγR engagement and type I interferon signaling
7天前
已完结
Fc glycoengineering of a PD-L1 antibody harnesses Fcγ receptors for increased antitumor efficacy
7天前
已完结
Fcγ receptors and immunomodulatory antibodies in cancer
7天前
已完结
Nanobody-based bispecific antibody engagers targeting CTLA-4 or PD-L1 for cancer immunotherapy
10天前
已完结
Fc-optimized checkpoint antibodies for cancer immunotherapy
10天前
已完结
The rise of China’s pharmaceutical industry from 2015–2024: a decade of innovation
1个月前
已完结
Enhanced CAR–T cell activity against solid tumors by vaccine boosting through the chimeric receptor
1个月前
已完结
皖公网安备34019202002308
